Showing results (141-150 of 175) with videos related to
Sort By:
Pageof 18
American Journal of Clinical Oncology|April 16, 1998
Amonafide in patients with leiomyosarcoma of the uterus: a phase II Gynecologic Oncology Group studyR Asbury, J A Blessing, R Buller, et al.Investigational New Drugs|January 1, 1984
Phase II evaluation of dianhydrogalactitol in the treatment of advanced non-squamous cervical carcinoma. A Gynecologic Oncology Group studyF B Stehman, J A Blessing, H D Homesley, et al.American Journal of Obstetrics and Gynecology|August 1, 1992
Ifosfamide alone and in combination in the treatment of refractory malignant gestational trophoblastic diseaseG P Sutton, J T Soper, J A Blessing, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 26, 2007
Phase II evaluation of capecitabine in refractory nonsquamous cell carcinoma of the cervix: a Gynecologic Oncology Group studyK Y Look, J A Blessing, C M Michener, et al.American Journal of Clinical Oncology|February 1, 1986
ICRF-159 (razoxane) in patients with advanced adenocarcinoma of the endometrium. A Gynecologic Oncology Group StudyH D Homesley, J A Blessing, J Conroy, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1994
A randomized comparison of doxorubicin alone versus doxorubicin plus cyclophosphamide in the management of advanced or recurrent endometrial carcinoma: A Gynecologic Oncology Group studyJ T Thigpen, J A Blessing, P J DiSaia, et al.American Journal of Clinical Oncology|August 1, 1992
Echinomycin (NSC 526417) in recurrent and metastatic nonsquamous cell carcinoma of the cervix. A phase II trial of the Gynecologic Oncology GroupH B Muss, J A Blessing, P Hanjani, et al.Gynecologic Oncology|April 1, 1992
Characteristics of patients with small-volume residual ovarian cancer unresponsive to cisplatin-based ip chemotherapy: lessons learned from a Gynecologic Oncology Group phase II trial of ip cisplatin and recombinant alpha-interferonM Markman, J S Berek, J A Blessing, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1985
Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: a Gynecologic Oncology Group studyP Bonomi, J A Blessing, F B Stehman, et al.Cancer|July 15, 1985
Vincristine, dactinomycin, and cyclophosphamide in the treatment of malignant germ cell tumors of the ovary. A Gynecologic Oncology Group Study (a final report)R E Slayton, R C Park, S G Silverberg, et al.Pageof 18